| D |
2026-06-08 16:15 |
2026-06-05 |
ACRS |
Aclaris Therapeutics, Inc. |
Molineaux Christopher P. |
Dir |
M - OptEx |
— |
+11.6K |
69.5K |
+20% |
— |
| D |
2025-06-09 |
2025-06-06 |
ACRS |
Aclaris Therapeutics, Inc. |
Molineaux Christopher P. |
Dir |
M - OptEx |
— |
+4,793 |
58.0K |
+9% |
— |
| D |
2024-06-04 |
2024-06-01 |
ACRS |
Aclaris Therapeutics, Inc. |
Molineaux Christopher P. |
Dir |
M - OptEx |
— |
+4,660 |
53.2K |
+10% |
— |
| D |
2023-06-22 |
2023-06-20 |
ACRS |
Aclaris Therapeutics, Inc. |
Molineaux Christopher P. |
Dir |
M - OptEx |
$1.41 |
+16.5K |
48.5K |
+52% |
+$23.3K |
| DM |
2023-06-20 |
2023-06-15 |
ACRS |
Aclaris Therapeutics, Inc. |
Molineaux Christopher P. |
Dir |
M - OptEx |
$1.36 |
+249 |
32.0K |
+0.8% |
+$337.68 |
| D |
2023-06-05 |
2023-06-02 |
ACRS |
Aclaris Therapeutics, Inc. |
Molineaux Christopher P. |
Dir |
M - OptEx |
— |
+4,507 |
31.8K |
+17% |
— |
| D |
2022-06-06 |
2022-06-03 |
ACRS |
Aclaris Therapeutics, Inc. |
Molineaux Christopher P. |
Dir |
M - OptEx |
— |
+3,356 |
27.2K |
+14% |
— |